RA CAPITAL MANAGEMENT, L.P.
BOSTON, MA · CIK 1346824 · 13F filing filed 2022-08-15
SEC-registered investment adviser since 2012 · limited partnership
- Assets managed$16.4bn
- Staff185 · 95 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds6 (1 hedge) · $16.3bn gross assets
- Websiteracap.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityRA CAPITAL MANAGEMENT, L.P. (US)
- Kindhedge funds, venture, futures
- Others nearbyBoston, MA, New York, NY, San Francisco, CA
As an employer
- Offices in1 country
- Private fundshedge 1, venture capital 5
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Boston, MA (main office)United States | about 89 |
| New York, NYUnited States | 4 |
| San Francisco, CAUnited States | 2 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ASCENDIS PHARMA A/S SPONSORED ADR | $703.5m18.76% | Unchanged |
| BIOGEN INC BIIB | $148.3m3.95% | Unchanged |
| CYTEK BIOSCIENCES INC CTKB | $143.6m3.83% | Unchanged |
| AEROVATE THERAPEUTICS INC COM | $129.2m3.44% | Unchanged |
| DAY ONE BIOPHARMACEUTICALS I COM | $126.0m3.36% | Added +980.5k |
| TRAVERE THERAPEUTICS INC TVTX | $119.3m3.18% | Unchanged |
| JANUX THERAPEUTICS INC JANX | $105.9m2.82% | Unchanged |
| VAXCYTE INC PCVX | $99.7m2.66% | Unchanged |
| IMMUNOGEN INC IMGN | $97.8m2.61% | Unchanged |
| NKARTA INC NKTX | $96.2m2.56% | Added +2.2m |
| BELLUS HEALTH INC NEW BLU | $94.5m2.52% | Unchanged |
| ITEOS THERAPEUTICS INC ITOS | $91.0m2.43% | Unchanged |
| VERU INC COM | $89.3m2.38% | New |
| DICE THERAPEUTICS INC COM | $80.8m2.16% | Unchanged |
| PEPGEN INC PEPG | $80.8m2.15% | New |
| FORMA THERAPEUTICS HLDGS INC SHS | $62.1m1.66% | Unchanged |
| ACLARIS THERAPEUTICS INC ACRS | $61.4m1.64% | Added +2.6m |
| POINT BIOPHARMA GLOBAL INC COM | $61.3m1.63% | Unchanged |
| CELLDEX THERAPEUTICS INC NEW CLDX | $55.9m1.49% | Unchanged |
| WAVE LIFE SCIENCES LTD 96663EUR | $55.9m1.49% | Added +9.4m |
| VOR BIOPHARMA INC COM | $55.3m1.47% | Unchanged |
| KINNATE BIOPHARMA INC KNTE | $53.8m1.43% | Unchanged |
| TYRA BIOSCIENCES INC TYRA | $51.7m1.38% | Unchanged |
| GH RESEARCH PLC GHRS | $48.9m1.30% | Added +71.0k |
| GERON CORP GERN | $46.7m1.25% | Unchanged |
| NATERA INC NTRA | $46.4m1.24% | Unchanged |
| ACUMEN PHARMACEUTICALS INC ABOS | $45.9m1.22% | Unchanged |
| NANOSTRING TECHNOLOGIES INC NSTG | $45.5m1.21% | New |
| RXSIGHT INC RXST | $43.0m1.15% | Unchanged |
| ENANTA PHARMACEUTICALS INC ENTA | $42.4m1.13% | Reduced -67.5k |
| CLIMB BIO INC CLYM | $39.7m1.06% | Unchanged |
| RELMADA THERAPEUTICS INC RLMD | $38.0m1.01% | Unchanged |
| INSTIL BIO INC COM | $35.4m0.94% | Added +2.8m |
| ICOSAVAX INC COM | $34.2m0.91% | Unchanged |
| AVIDITY BIOSCIENCES INC RNA | $31.5m0.84% | Unchanged |
| DESIGN THERAPEUTICS INC DSGN | $30.6m0.82% | Unchanged |
| AN2 THERAPEUTICS INC ANTX | $29.1m0.77% | Added +81.7k |
| ROCKET PHARMACEUTICALS INC RCKT | $29.0m0.77% | Unchanged |
| EYEPOINT PHARMACEUTICALS INC EYPT | $26.5m0.71% | Unchanged |
| 89BIO INC ETNB | $25.1m0.67% | Added +2.8m |
| SATSUMA PHARMACEUTICALS INC STSA | $24.5m0.65% | Unchanged |
| PMV PHARMACEUTICALS INC PMVP | $24.4m0.65% | Unchanged |
| VERA THERAPEUTICS INC VERA | $21.5m0.57% | Reduced -387.3k |
| VERONA PHARMA PLC VRNA | $21.4m0.57% | Unchanged |
| RHYTHM PHARMACEUTICALS INC RYTM | $20.2m0.54% | Unchanged |
| TENAYA THERAPEUTICS INC TNYA | $20.0m0.53% | Unchanged |
| DYNE THERAPEUTICS INC DYN | $19.3m0.51% | Unchanged |
| HILLEVAX INC COM | $19.2m0.51% | New |
| GUARDANT HEALTH INC GH | $19.2m0.51% | Unchanged |
| PARDES BIOSCIENCES INC COM | $19.0m0.51% | Unchanged |
| WEREWOLF THERAPEUTICS INC HOWL | $17.6m0.47% | Unchanged |
| DA32 LIFE SCNCE TEC ACQSTN C CLASS A COM | $14.5m0.39% | Unchanged |
| CONCERT PHARMACEUTICALS INC CNCE | $13.9m0.37% | Added +273.6k |
| MILESTONE PHARMACEUTICALS IN MIST | $13.8m0.37% | Unchanged |
| ACHILLES THERAPEUTICS PLC SPONSORED ADS | $12.6m0.34% | Unchanged |
| BCLS ACQUISITION CORP COM CL A | $12.4m0.33% | Unchanged |
| OTONOMY INC OTIC | $11.6m0.31% | Unchanged |
| LIANBIO LIANY | $10.0m0.27% | Reduced -3.0m |
| FRAZIER LIFESCIENCES ACQU CO UNIT 12/09/2025 | $9.9m0.26% | Unchanged |
| ARYA SCIENCES ACQUISITN CORP CLASS A ORD SHS | $9.7m0.26% | Unchanged |
| RELAY THERAPEUTICS INC RLAY | $9.2m0.25% | Unchanged |
| IO BIOTECH INC IOBTQ | $8.7m0.23% | Unchanged |
| SOLID BIOSCIENCES INC COM | $7.6m0.20% | Unchanged |
| 5 01 ACQUISITION CORP COM CL A | $7.4m0.20% | Unchanged |
| SYNLOGIC INC COM | $6.7m0.18% | Reduced -840.8k |
| BLACK DIAMOND THERAPEUTICS I BDTX | $6.4m0.17% | Unchanged |
| CENTURY THERAPEUTICS INC IPSC | $6.4m0.17% | Reduced -157.3k |
| HEALTH SCIENCES ACQ CORP 2 OBIO | $6.2m0.17% | Unchanged |
| CONNECT BIOPHARMA HLDGS LTD ADS | $6.1m0.16% | Unchanged |
| BIOMEA FUSION INC BMEA | $6.0m0.16% | Unchanged |
| ATHIRA PHARMA INC COM | $5.7m0.15% | New |
| XILIO THERAPEUTICS INC COM | $4.8m0.13% | Reduced -352.5k |
| AADI BIOSCIENCE INC WHWK | $4.7m0.13% | New |
| STANDARD BIOTOOLS INC LAB | $3.2m0.08% | New |
| ENTERA BIO LTD ENTX | $3.1m0.08% | Unchanged |
| TERNS PHARMACEUTICALS INC COM | $3.1m0.08% | New |
| BIOATLA INC BCAB | $2.9m0.08% | New |
| ASTRIA THERAPEUTICS INC CATB | $2.3m0.06% | Reduced -501.3k |
| PYXIS ONCOLOGY INC PYXS | $2.3m0.06% | Reduced -1.3m |
| ADVERUM BIOTECHNOLOGIES INC COM | $2.1m0.06% | New |
| LARIMAR THERAPEUTICS INC LRMR | $2.0m0.05% | Reduced -250.4k |
| ORCHARD THERAPEUTICS PLC ORTX | $1.8m0.05% | Reduced -6.7m |
| CVRX INC CVRX | $1.7m0.04% | Unchanged |
| SENSEI BIOTHERAPEUTICS INC SNSE | $1.6m0.04% | New |
| OLEMA PHARMACEUTICALS INC OLMA | $952.0k0.03% | Reduced -270.7k |
| BOLT BIOTHERAPEUTICS INC COM | $918.0k0.02% | New |
| AVROBIO INC COM | $515.0k0.01% | New |
| CALADRIUS BIOSCIENCES INC NBS | $399.0k0.01% | New |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| MIRATI THERAPEUTICS INC MRTX | $60.4m734.3k shares |
| MACROGENICS INC MGNX | $53.8m6.1m shares |
| NOVAVAX INC NVAX | $51.0m692.8k shares |
| CENTESSA PHARMACEUTICALS PLC | $32.1m3.6m shares |
| CHEMOCENTRYX INC CCXI | $29.0m1.2m shares |
| KALVISTA PHARMACEUTICALS INC KALV | $28.5m1.9m shares |
| EDGEWISE THERAPEUTICS INC EWTX | $25.4m2.6m shares |
| TANGO THERAPEUTICS INC TNGX | $17.1m2.2m shares |
| CHINOOK THERAPEUTICS INC ADRO | $16.4m1.0m shares |
| SCPHARMACEUTICALS INC SCPH | $15.1m2.7m shares |
| KALA PHARMACEUTICALS INC | $15.0m10.9m shares |
| GRAPHITE BIO INC GRPH | $13.8m2.7m shares |
| CYTEIR THERAPEUTICS INC | $12.6m3.4m shares |
| MORPHIC HLDG INC MORF | $11.2m278.9k shares |
| AKOUOS INC | $10.8m2.3m shares |
| ALLOVIR INC | $9.7m1.4m shares |
| VERVE THERAPEUTICS INC | $7.1m310.3k shares |
| CUE HEALTH INC HLTHQ | $4.8m750.0k shares |
| PHASEBIO PHARMACEUTICALS INC PHAS | $3.8m2.9m shares |
| CULLINAN THERAPEUTICS INC CGEM | $3.7m350.0k shares |
| TSCAN THERAPEUTICS INC TCRX | $2.9m1.0m shares |
| COMPASS THERAPEUTICS INC CMPX | $730.0k533.0k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 77.
| Company | Stake |
|---|---|
| ARTIVA BIOTHERAPEUTICS INC ARTV · 13D · filed 2026-07-23 | 37.9%≈ $178.6m |
| CLIMB BIO INC CLYM · 13D · filed 2026-07-07 | 33.0%≈ $271.9m |
| VOR BIOPHARMA INC 13D · filed 2025-06-27 | 31.8% |
| ACUMEN PHARMACEUTICALS INC ABOS · 13D · filed 2026-03-17 | 29.5%≈ $56.3m |
| PEPGEN INC PEPG · 13D · filed 2025-09-30 | 29.2%≈ $36.2m |
| ACRIVON THERAPEUTICS INC ACRV · 13D · filed 2026-04-23 | 28.8%≈ $21.9m |
| SPYGLASS PHARMA INC SGP · 13D · filed 2026-02-17 | 24.1%≈ $178.6m |
| PARABILIS MEDICINES INC PBLS · 13D · filed 2026-06-18 | 23.8%≈ $791.9m |
| TYRA BIOSCIENCES INC TYRA · 13D · filed 2026-09-17 | 19.9%≈ $417.2m |
| VOR BIOPHARMA INC VOR · 13D · filed 2026-07-21 | 19.9%≈ $238.2m |
| JANUX THERAPEUTICS INC JANX · 13D · filed 2025-03-10 | 19.9%≈ $183.9m |
| WAVE LIFE SCIENCES LTD 96663EUR · 13D · filed 2026-04-17 | 17.1%≈ $198.9m |
| Wave Life Sciences Inc. WVE · 13D · filed 2026-08-11 | 16.8% |
| HEMAB THERAPEUTICS HLDGS INC COAG · 13G · filed 2026-05-11 | 16.6%≈ $283.9m |
| SIONNA THERAPEUTICS INC SION · 13D · filed 2026-09-21 | 14.3%≈ $284.9m |
| LENZ THERAPEUTICS INC LENZ · 13D · filed 2025-11-07 | 13.6%≈ $24.2m |
| SOLID BIOSCIENCES INC SLDB · 13D · filed 2026-06-24 | 11.9%≈ $120.2m |
| SEPTERNA INC SEPN · 13D · filed 2026-08-14 | 11.8%≈ $185.0m |
| BICARA THERAPEUTICS INC BCAX · 13D · filed 2026-03-02 | 11.5%≈ $216.1m |
| ARS PHARMACEUTICALS INC SPRY · 13D · filed 2025-10-01 | 11.1%≈ $87.6m |
| CORBUS PHARMACEUTICALS HLDGS CRBP · 13G · filed 2026-09-30 | 9.9%≈ $18.0m |
| ADICET BIO INC ACET · 13G · filed 2026-08-14 | 9.9%≈ $8.1m |
| GERON CORP GERN · 13G · filed 2026-08-14 | 9.9%≈ $85.1m |
| OVID THERAPEUTICS INC OVID · 13G · filed 2026-08-14 | 9.9%≈ $52.6m |
| RANI THERAPEUTICS HLDGS INC RANI · 13G · filed 2026-08-14 | 9.9%≈ $8.8m |
Trades reported as a company insider in Q2 2022
Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.
| Date | Company | Trade | Value |
|---|---|---|---|
| 2022-06-21 | AN2 THERAPEUTICS INC 10% owner · See footnotes | Bought | $2.4k302 shares |
| 2022-06-16 | Wave Life Sciences Inc. Director · See Footnotes | Bought | $20.4m9.5m shares |
| 2022-06-14 | AN2 THERAPEUTICS INC 10% owner · See footnotes | Bought | $489.5k61.4k shares |
| 2022-06-13 | AN2 THERAPEUTICS INC 10% owner · See footnotes | Bought | $158.0k20.0k shares |
| 2022-05-26 | KALA BIO INC 10% owner · See Footnotes | Sold | $362.0k1.0m shares |
| 2022-05-25 | KALA BIO INC 10% owner · See Footnotes | Sold | $602.5k1.4m shares |
| 2022-05-24 | KALA BIO INC 10% owner · See Footnotes | Sold | $73.9k144.8k shares |
| 2022-05-23 | KALA BIO INC 10% owner · See Footnotes | Sold | $812.5k1.2m shares |
| 2022-05-10 | PEPGEN INC Director · See footnotes | Bought | $38.8m3.2m shares |
| 2022-04-26 | NKARTA INC Director · See Footnotes | Bought | $33.0m2.2m shares |